Organo Corporation
Q2 (Interim) Financial Supplementary Materials
Published consolidated financial overview for Q2 including first-half results and full-year projections. Revenue for the first half was 70,549 million yen, full-year results 151,961 million yen; operating income was 15,771 million yen for the first half and 37,648 million yen for the full year. Segment information covers Plant, Solutions, Functional Products, Pharmaceuticals, Equipment & Functional Materials, and Food. Full-year forecast indicates improvement to revenue of 200,000 million yen and operating income of 40,000 million yen, though declines in margins are suggested in some divisions. Regional breakdowns and outlook for orders and revenue in Japan, Taiwan, China, and Europe/US are provided. FX information: JPY/USD = 0.0063175.
Key Figures
- Revenue: First half 70,549 million yen / Full year 177,654 million yen / Full-year forecast 200,000 million yen
- Operating Income: First half 15,771 million yen / Full year 37,648 million yen / Full-year forecast 40,000 million yen
- Orders Received: First half 87,294 million yen / Full year 141,685 million yen / Full-year forecast 273,000 million yen
AI要約
Performance Overview
These materials are supplementary documents presenting the consolidated financial overview for the second quarter of the fiscal year ending March 2027, showing first-half results and full-year forecasts. Segment-level sales, orders and operating income are disclosed by division. Consolidated revenue was 70,549 million yen for the first half and 177,654 million yen for the full year; operating income was 17,378 million yen for the first half and 37,648 million yen for the full year. The full-year forecast is revenue of 200,000 million yen and operating income of 40,000 million yen.
Outlook and Points to Note
The company discloses the composition of sales and orders by region and segment, and market trends in Japan, Taiwan, China and Europe/US may affect future results. In particular, some segments may experience declining margins, and attention should be paid to cost structure, foreign exchange movements and demand fluctuations.
Organo Corporation
Company overview · Stock price · Financial data · All IR
